NCT05976178

Brief Summary

It is described in the literature a higher prevalence of pain in patients with an addiction but there are few studies describing the pain profile of patients with use disorder. Pain has a very negative impact on the quality of life of opioid substituted patients. Improving knowledge on this point would make it possible to better guide specific care. The investigator proposes to conduct a single-center descriptive observational study using questionnaires, without changing the management of patients with chronic pain. The primary objective of the study is to determine the prevalence of chronic pain in patients with substance addiction hospitalized for addiction treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 10, 2022

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

July 11, 2023

Completed
24 days until next milestone

First Posted

Study publicly available on registry

August 4, 2023

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
Last Updated

May 11, 2025

Status Verified

May 1, 2025

Enrollment Period

2.2 years

First QC Date

July 11, 2023

Last Update Submit

May 7, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Prevalence of chronic pain in patients with substance addiction hospitalized for addiction treatment.

    Percentage of patients presenting with pain for more than three months among patients hospitalized in an addiction service for the management of an addiction

    During the hospitalization, maximum 1 month

Secondary Outcomes (8)

  • Pain intensity in the last 24 hours

    During the hospitalization, maximum 1 month

  • Interference of pain on the quality of life

    During the hospitalization, maximum 1 month

  • Localisation of pain

    During the hospitalization, maximum 1 month

  • Describe the frequency of the two main psychiatric comorbidities of chronic pain: anxiety

    During the hospitalization, maximum 1 month

  • Describe the frequency of the two main psychiatric comorbidities of chronic pain: depression

    During the hospitalization, maximum 1 month

  • +3 more secondary outcomes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients hospitalized in the addictology department of LORIENT Hospital, in full hospitalization or in a day hospital

You may qualify if:

  • \> 18 years old
  • Presence of addiction to at least one substance, based on DSM-5 criteria
  • Hospitalized in the addiction service of LORIENT Hospital
  • Knowing how to read and write French
  • Not objecting to their participation in the study after informed information

You may not qualify if:

  • Already included during a precedent hospitalization
  • Adults subject to legal protection or deprived of their liberty.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Groupe Hospitalier Bretagne Sud

Lorient, 56100, France

Location

Related Publications (5)

  • Rosenblum A, Joseph H, Fong C, Kipnis S, Cleland C, Portenoy RK. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA. 2003 May 14;289(18):2370-8. doi: 10.1001/jama.289.18.2370.

    PMID: 12746360BACKGROUND
  • Lusted A, Roerecke M, Goldner E, Rehm J, Fischer B. Prevalence of pain among nonmedical prescription opioid users in substance use treatment populations: systematic review and meta-analyses. Pain Physician. 2013 Nov-Dec;16(6):E671-84.

    PMID: 24284850BACKGROUND
  • Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006 May;10(4):287-333. doi: 10.1016/j.ejpain.2005.06.009. Epub 2005 Aug 10.

    PMID: 16095934BACKGROUND
  • Voon P, Greer AM, Amlani A, Newman C, Burmeister C, Buxton JA. Pain as a risk factor for substance use: a qualitative study of people who use drugs in British Columbia, Canada. Harm Reduct J. 2018 Jul 5;15(1):35. doi: 10.1186/s12954-018-0241-y.

    PMID: 29976203BACKGROUND
  • Larson MJ, Paasche-Orlow M, Cheng DM, Lloyd-Travaglini C, Saitz R, Samet JH. Persistent pain is associated with substance use after detoxification: a prospective cohort analysis. Addiction. 2007 May;102(5):752-60. doi: 10.1111/j.1360-0443.2007.01759.x.

    PMID: 17506152BACKGROUND

MeSH Terms

Conditions

Chronic PainBehavior, Addictive

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsCompulsive BehaviorImpulsive BehaviorBehavior

Study Officials

  • Alexandre Cauchie, MD

    GH Bretagne Sud

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 11, 2023

First Posted

August 4, 2023

Study Start

December 10, 2022

Primary Completion

March 1, 2025

Study Completion

March 1, 2025

Last Updated

May 11, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations